Are the Weight-loss Drugs Worth It?
Under optimal conditions and with mindful compliance, what can be expected from weight-loss drugs?
Online Weight-Loss Drug Providers Pivot to HRT
The intersection of weight-loss treatments and menopause care is creating new opportunities for both patients and healthcare providers.
FDA Ends Compounding for Popular GLP-1 Drugs
Consumers who have relied on less expensive, compounded versions — often obtained through telehealth services or medical spas — will need to find other options.
The “Miracle Drugs” Are Not Without Risk
While GLP-1RA medications offer broad health benefits, one recent study underscores that they are not without risks.
Study Finds That Weight Loss Drugs Reduce Alcohol Craving
A recent study found that moderate drinkers who use weight-loss drugs like Mounjaro tend to drink less alcohol.
GLP-1 Drugs — Are Alternatives Feasible?
What problems with Ozempic (and other semaglutide brands) have natural alternatives been found to avoid?
GLP-1 Drugs and Babies, Part 2
Some studies indicate that GLP-1 drugs in conjunction with pregnancy do pose a risk, but the FDA still warns women not to take them during pregnancy.
GLP-1 Drugs and Babies
What is going on with the relationship between the GLP-1 genre of weight-loss medications and the creation of new humans?
Researching the Differences in Weight Loss Drugs
Research shows that weight loss drugs, despite their similar mechanisms, can vary in effectiveness.
GLP-1 Drugs — the Questions Continue
By selling weight-loss meds that only work as long as people are taking them, the companies guarantee that sales of GLP-1 drugs will continue into infinity.